Suppr超能文献

使用功能位点相互作用指纹图谱方法描绘人类结构激酶组中的多药理学特征。

Delineation of Polypharmacology across the Human Structural Kinome Using a Functional Site Interaction Fingerprint Approach.

作者信息

Zhao Zheng, Xie Li, Xie Lei, Bourne Philip E

机构信息

National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health , Bethesda, Maryland 20894, United States.

Scripps Ranch , San Diego, California 92131, United States.

出版信息

J Med Chem. 2016 May 12;59(9):4326-41. doi: 10.1021/acs.jmedchem.5b02041. Epub 2016 Mar 17.

Abstract

Targeted polypharmacology of kinases has emerged as a promising strategy to design efficient and safe therapeutics. Here, we perform a systematic study of kinase-ligand binding modes for the human structural kinome at scale (208 kinases, 1777 unique ligands, and their complexes) by integrating chemical genomics and structural genomics data and by introducing a functional site interaction fingerprint (Fs-IFP) method. New insights into kinase-ligand binding modes were obtained. We establish relationships between the features of binding modes, the ligands, and the binding pockets, respectively. We also drive the intrinsic binding specificity and which correlation with amino acid conservation. Third, we explore the landscape of the binding modes and highlight the regions of "selectivity pocket" and "selectivity entrance". Finally, we demonstrate that Fs-IFP similarity is directly correlated to the experimentally determined profile. These improve our understanding of kinase-ligand interactions and contribute to the design of novel polypharmacological therapies targeting kinases.

摘要

激酶的靶向多药理学已成为设计高效且安全疗法的一种有前景的策略。在此,我们通过整合化学基因组学和结构基因组学数据,并引入功能位点相互作用指纹(Fs-IFP)方法,对人类结构激酶组的激酶-配体结合模式进行了大规模系统研究(208种激酶、1777种独特配体及其复合物)。获得了关于激酶-配体结合模式的新见解。我们分别建立了结合模式特征、配体和结合口袋之间的关系。我们还揭示了内在结合特异性及其与氨基酸保守性的相关性。第三,我们探索了结合模式的格局,并突出了“选择性口袋”和“选择性入口”区域。最后,我们证明Fs-IFP相似性与实验确定的概况直接相关。这些增进了我们对激酶-配体相互作用的理解,并有助于设计针对激酶的新型多药理学疗法。

相似文献

4
KiSSim: Predicting Off-Targets from Structural Similarities in the Kinome.KiSSim:从激酶组中的结构相似性预测脱靶。
J Chem Inf Model. 2022 May 23;62(10):2600-2616. doi: 10.1021/acs.jcim.2c00050. Epub 2022 May 10.

引用本文的文献

2
Advances in reversible covalent kinase inhibitors.可逆共价激酶抑制剂的研究进展。
Med Res Rev. 2025 Mar;45(2):629-653. doi: 10.1002/med.22084. Epub 2024 Sep 17.
5
How Ligands Interact with the Kinase Hinge.配体如何与激酶铰链区相互作用。
ACS Med Chem Lett. 2023 Oct 9;14(11):1503-1508. doi: 10.1021/acsmedchemlett.3c00212. eCollection 2023 Nov 9.
6
Rigid Scaffolds Are Promising for Designing Macrocyclic Kinase Inhibitors.刚性支架在设计大环激酶抑制剂方面颇具前景。
ACS Pharmacol Transl Sci. 2023 Jul 7;6(8):1182-1191. doi: 10.1021/acsptsci.3c00078. eCollection 2023 Aug 11.

本文引用的文献

1
Historeceptomic Fingerprints for Drug-Like Compounds.类药物化合物的组织受体组学指纹图谱。
Front Physiol. 2015 Dec 18;6:371. doi: 10.3389/fphys.2015.00371. eCollection 2015.
2
Osimertinib: First Global Approval.奥希替尼:全球首次获批。
Drugs. 2016 Feb;76(2):263-73. doi: 10.1007/s40265-015-0533-4.
5
Small-molecule kinase inhibitors: an analysis of FDA-approved drugs.小分子激酶抑制剂:FDA 批准药物分析。
Drug Discov Today. 2016 Jan;21(1):5-10. doi: 10.1016/j.drudis.2015.07.008. Epub 2015 Jul 23.
7
FDA-approved small-molecule kinase inhibitors.美国食品和药物管理局批准的小分子激酶抑制剂。
Trends Pharmacol Sci. 2015 Jul;36(7):422-39. doi: 10.1016/j.tips.2015.04.005. Epub 2015 May 12.
9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验